STOCK TITAN
  1. Home
  2. Sec-filings
  3. PLUR
  4. [8-K] Pluri Inc. Reports Material Event

Pluri Inc. (NASDAQ: PLUR) in constructive talks on €20M EIB loan

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K

Rhea-AI Filing Summary

Pluri Inc. reports on ongoing discussions with the European Investment Bank regarding a finance agreement that provides for up to €50 million in funding, of which a first tranche of €20 million was drawn in June 2021 at 4% per annum and was due June 1, 2026.

The company states that since April 21, 2026 it has been in constructive talks with the EIB about potential alternatives, including a possible maturity extension. The EIB indicated discussions are advancing constructively, subject to internal approvals and legal review, but Pluri cautions there is no assurance of approvals, a definitive resolution, or continued forbearance from EIB remedies.

Positive

  • None.

Negative

  • None.
Item 8.01 Other Events Other
Voluntary disclosure of events the company deems important to shareholders but not covered by other items.
Finance facility size €50 million Total funding available under the finance agreement with the EIB
Disbursed loan tranche €20 million First tranche drawn in June 2021 under the EIB finance agreement
Interest rate 4% per annum Interest on the €20 million tranche from the EIB
Original maturity date June 1, 2026 Scheduled repayment date for the €20 million EIB loan tranche
Negotiation period reference date July 3, 2026 Date beyond which EIB said discussions were not expected to extend
Initial rights reservation notice April 21, 2026 Date EIB reserved all rights while exploring alternatives
Constructive discussions confirmation May 28, 2026 Date EIB confirmed constructive talks and temporary non-enforcement stance
finance agreement financial
"entered into a finance agreement with the European Investment Bank"
European Investment Bank financial
"entered into a finance agreement with the European Investment Bank"
remedies under the finance agreement regulatory
"the EIB will continue to refrain from exercising remedies available to it"
forward-looking statements regulatory
"contains express or implied forward-looking statements within the meaning"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
liquidity position financial
"the Company’s liquidity position and need for additional financing"
Liquidity position describes how much cash and easily converted-into-cash assets an organization has relative to its upcoming bills and obligations. Think of it like a household’s checking account and emergency fund: it shows whether the business can pay short-term costs, cover debt and handle surprises without selling long-term investments. Investors care because a stronger liquidity position reduces the risk of bankruptcy, supports operations and gives flexibility for opportunities or downturns.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Understanding 8-K Material Events →

FAQ

What are the key terms of Pluri (PLUR)'s loan from the European Investment Bank?
Pluri has a finance agreement with the EIB for up to €50 million, of which €20 million was disbursed in June 2021. That tranche bears 4% annual interest and was scheduled to become repayable on June 1, 2026, prompting current discussions on potential alternatives.

What update did Pluri (PLUR) provide on its negotiations with the EIB?
Pluri reports that discussions with the EIB over the €20 million loan are advancing constructively and remain ongoing. The EIB has indicated progress, subject to its internal approval process and legal review, but no definitive resolution or approvals have yet been confirmed by the parties.

Did the EIB pause enforcement actions on Pluri (PLUR)'s loan, and for how long?
The EIB advised it did not contemplate enforcement action while negotiations continued through July 3, 2026, without prejudice to its rights. After that date, Pluri states discussions have remained active, but there is no assurance the EIB will continue refraining from exercising remedies under the finance agreement.

What is the recent timeline of communications between Pluri (PLUR) and the EIB?
On April 21, 2026 the EIB reserved its rights while exploring alternatives, and on May 28, 2026 confirmed constructive talks expected not to extend beyond July 3, 2026. Pluri states that after July 3 it has remained in active discussions and recent communications describe progress as constructive.
false 0001158780 0001158780 2026-07-14 2026-07-14 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC  20549

 

FORM 8-K

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported): July 14, 2026

 

PLURI INC.

(Exact Name of Registrant as Specified in Its Charter)

 

Nevada   001-31392   98-0351734
(State or Other Jurisdiction
of Incorporation)		   (Commission File Number)   (IRS Employer
Identification No.)

 

MATAM Advanced Technology Park    
Building No. 5    
Haifa, Israel   3508409
(Address of Principal Executive Offices)   (Zip Code)

 

011 972 74 710 7171

(Registrant’s telephone number, including area code)

 

 

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

☐Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Common Shares, par value $0.00001 per share   PLUR   The Nasdaq Capital Market

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

 

Item 8.01 Other Events.

 

As previously disclosed, Pluri Inc. (the “Company”), together with its subsidiaries, Pluri Biotech Ltd., incorporated under the laws of Israel, and Pluristem GmbH, incorporated under the laws of Germany, entered into a finance agreement with the European Investment Bank (“EIB”) providing for up to €50 million in funding, of which only the first tranche of €20 million was disbursed in June 2021, and such amount bears interest at 4% per annum, and was scheduled to become repayable on June 1, 2026 (the “EIB Loan”). The Company also previously disclosed that on April 21, 2026, the Company received notice from the EIB that the EIB was reserving all of its rights under the finance agreement while discussions concerning potential alternatives, including a possible extension of the maturity date, remained ongoing.

 

On May 28, 2026, the EIB confirmed to the Company that the parties remain engaged in constructive discussions in good faith with the objective of exploring a mutually agreed resolution regarding the EIB Loan. The EIB further advised that such discussions and negotiations were not expected to extend beyond July 3, 2026, and that during that period, and without prejudice to any of the EIB’s rights and remedies, no enforcement action was contemplated while discussions remained ongoing.

 

Following July 3, 2026, the Company remained in active discussions with the EIB regarding a potential resolution of matters relating to the EIB Loan. In recent communications, the EIB has indicated that discussions are advancing constructively and are subject to its internal approval process and legal review. No assurance can be given that the required approvals will be obtained, that the parties will reach a definitive resolution, or that the EIB will continue to refrain from exercising remedies available to it under the finance agreement.

 

Cautionary Note Regarding Forward-Looking Statements

 

This Current Report on Form 8-K contains express or implied forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and other U.S. federal securities laws. Forward-looking statements include, but are not limited to, statements regarding ongoing discussions with the EIB; the status of the EIB’s review and approval process; receipt of the required approvals; ongoing discussions and potential resolution of matters relating to the EIB Loan; and that the EIB will continue to refrain from exercising remedies available to it under the finance agreement . Words such as “may”, “will”, “should”, “could”, “would”, “expect”, “intend”, “plan”, “believe”, “estimate”, “target”, “potential”, “continue”, “anticipate”, “seek”, and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words.

 

Forward-looking statements are based on management’s current expectations and are subject to risks and uncertainties that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Risks and uncertainties include, among others, the outcome and timing of the Company’s ongoing discussions with the EIB regarding the EIB Loan, whether the EIB’s internal approval process and legal review will be completed, whether those discussions result in a mutually agreed resolution, the Company’s liquidity position and need for additional financing, general market and economic conditions, the possibility that the EIB may exercise remedies under the finance agreement and other risks and uncertainties described under the heading “Risk Factors” in the Company’s most recent Annual Report on Form 10-K and in other filings the Company makes with the U.S. Securities and Exchange Commission (the “SEC”). Forward-looking statements speak only as of the date of this Current Report on Form 8-K. The Company undertakes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by law. For a more detailed description of the risks and uncertainties affecting the Company, reference is made to the Company’s reports filed from time to time with the Securities and Exchange Commission.

 

1

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PLURI INC.
   
Date: July 14, 2026 By: /s/ Liat Zalts
  Name:  Liat Zalts
  Title: Chief Financial Officer

 

 

2

 

 

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

3 documents

Other Documents